Action Point Financial Planning’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$296K Buy
1,876
+1,509
+411% +$238K 0.03% 359
2026
Q2
$58K Buy
+367
New +$49.6K 0.01% 771

Other funds holding XBI

Action Point Financial Planning's XBI Position: Q3 2026 in Review

Action Point Financial Planning increased its State Street SPDR S&P Biotech ETF (XBI) stake by 411% in Q3 2026, buying an estimated $238K and bringing the position to 1,876 shares worth $296K. The position accounts for 0.03% of the portfolio, ranked #359.

Action Point Financial Planning first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Action Point Financial Planning held 1,876 shares of State Street SPDR S&P Biotech ETF worth $296K as of Q3 2026.
  • Action Point Financial Planning bought 1,509 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $238K.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Action Point Financial Planning's portfolio in Q3 2026, its #359 holding.
  • Action Point Financial Planning first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
  • 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.